Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Trulicity ® (dulaglutide)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
Can multiple Trulicity® (dulaglutide) injections be used to make a larger dose?
Lilly does not recommend using multiple dulaglutide injections to make a larger dose.
Administering Multiple Injections
Administering multiple injections of dulaglutide has not been tested in a phase 3 clinical study, so there is limited evidence to support the efficacy and safety of administering multiple injections to create a higher dose. Using multiple dulaglutide injections is not captured in the Summary of Product Characteristics; therefore, Eli Lilly and Company does not recommend using multiple lower dose injections.1,2
1Data on file, Eli Lilly and Company and/or one of its subsidiaries.
2Trulicity [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: 14 January 2022